Research ArticleHEAD AND NECK
Evaluation of Head and Neck Squamous Cell Carcinoma After Treatment
Suresh K. Mukherji and Gregory T. Wolf
American Journal of Neuroradiology October 2003, 24 (9) 1743-1746;

References
- ↵Greene FL, Page DL, Fleming ID, eds. American Joint Committee on Cancer Manual for Staging of Cancer. 6th ed. Philadelphia: Lippincott-Raven;2002 :18
- ↵Lapela M, Eigtved A, Jyrkkio S, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 2000;36:858–867
- ↵Hudgins PA, Burson JG, Gussack GS, Grist WJ. CT and MR appearance of recurrent malignant head and neck neoplasms after resection and flap reconstruction. AJNR Am J Neuroradiol 1994;15:1689–1694
- ↵
- ↵Mukherji SK, Gapany M, Phillips D, et al. Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1999;20:1215–1220
- ↵Valdes Olmos RA, Balm AJM, Hilgers FJM, et al. Tl-201 SPECT in the diagnosis of head and neck cancer. J Nucl Med 1997;38:873–879
- Di Martino E, Nowak B, Hassam H, at al. Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emisson tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 2000;126:1457–1461
- ↵
- ↵Mukherji SK, Mancuso AA, Kotzur IM, et al. Radiographic appearance of the irradiated larynx. Part II. Primary site response. Radiology 1994;193:149–154
- ↵Glazer HS, Niemeyer DM, Balfe DM, et al. Neck neoplasms: MR imaging. Part II. Posttreatment evaluation. Radiology 1986;160:349–354
- ↵
- ↵Loevner LA, Sonners AI, Schulman BJ, et al. Reinterpretation of cross-sectional images in patients with head and neck cancer in the setting of a multidisciplinary cancer center. AJNR Am J Neuroradiol 2002;23:1622–1626
- ↵Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2- [F-18] fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135–141.
- ↵Bailet JW, Sercarz JA, Abemayor E, et al. The use of positron emission tomography for early detection of recurrent head and neck carcinoma in postradiotherapy patients. Laryngoscope 1995;105:135–139
- Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinoma after radiation therapy with 2–18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 1999;109:970–975
- Fischbein NJ, Aassar OS, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1998;19:1189–1196
- Greven KM, Williams DW III, Keyes JW Jr, et al. Distinguishing tumor recurrence from irratiation sequelae with positron emission tomography in patients treated for larynx cancer. Int J Radiat Oncol Biol Phys 1994;29:841–845
- Hanasono MM, Kunda LD, Segall GM, et al. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999;109:880–885
- Keyes JW Jr, Watson NE Jr, Williams DW III, et al. FDG PET in head and neck cancer. AJR Am J Roentgenol 1997;169:1663–1669
- Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 1995;197:205–211
- Manolidis S, Donald PJ, Valk P, Pounds TR. The use of positron emission tomography scanning in occult and recurrent head and neck cancer. Acta Otolaryngol Suppl (Stockh) 1998;534:1–11
- Paulus P, Sambon A, Vivegnis D, et al. 18FDG PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 1998;108:1578–1583
- Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancer. Cancer 1994;73:3047–3058.
- ↵
- ↵Nowak B, DiMartino E, Janicke S, et al. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin 1999;38:312–318
- ↵
- ↵Nagamachi S, Jinnouchi S, Flores LG, et al. The use of Tl-201 SPECT to predict the response to radiotherapy in patients with head and neck cancer. Nuc Med Comm 1996;17:935–942
- ↵Gregor T, Valdes-Olmes RA, Koops W, et al. Preliminary experience with thallous chloride Tl 201-labeled single-photon emission computed tomography scanning in head and neck cancer. Arch Otolaryngol Head Neck Surg 1996;122:509–514
- ↵Chong J, Chan L, Langstein HN, Ginsberg LE. MR imaging of the muscular component of myocutaneous flaps in the head and neck. AJNR Am J Neuroradiol 2001;22:170–174
In this issue
Advertisement
Suresh K. Mukherji, Gregory T. Wolf
Evaluation of Head and Neck Squamous Cell Carcinoma After Treatment
American Journal of Neuroradiology Oct 2003, 24 (9) 1743-1746;
0 Responses
Related Articles
- No related articles found.
Cited By...
- Detection of Local Recurrence in Patients with Head and Neck Squamous Cell Carcinoma Using Voxel-Based Color Maps of Initial and Final Area under the Curve Values Derived from DCE-MRI
- MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter
- Comparison between computed tomography and clinical evaluation in tumour/node stage and follow-up of oral cavity and oropharyngeal cancer
- Diffusion Magnetic Resonance Imaging: A Biomarker for Treatment Response in Oncology
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement